The majority of our work involves studies that support the development of new ocular therapies and devices. We have also participated in investigative studies that have advanced the field of preclinical development. You may also filter for Development phase, (e.g., Safety) ophthalmology discipline (e.g., ocular imaging) and therapeutic class (e.g., Gene and Cell therapies).
Publication Reference Index
Filter Results by...
|Investigation Type||Development Phase||Therapy Class||Discipline(s)|
Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR)
The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs